mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-05 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-05 |